News
12d
Zacks Investment Research on MSNRoche Gets CHMP Nod for Itovebi Combo in the EU for Breast CancerRoche RHHBY announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted ...
12d
Pharmaceutical Technology on MSNCHMP recommends GSK’s Blenrep approval for multiple myeloma treatmentCommittee for Medicinal Products for Human Use (CHMP) has recommended the approval of GSK’s Blenrep (belantamab mafodotin) ...
BeiGene's Tevimbra gets a highly sought after recommendation.
3d
Pharmaceutical Technology on MSNEC approves Takeda ADC plus chemo for stage IIb Hodgkin’s lymphomaThe European Commission (EC) has granted approval for Takeda's antibody-drug conjugate (ADC) Adcetris (brentuximab vedotin).
Fresenius Kabi (“Fresenius”) announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) had issued ...
The Committee for Medicinal Products for Human Use (CHMP) has recommended that Imfinzi be used in combination with ...
The new infusion for maple syrup urine disease is for patients who cannot have an oral or enteral branched-chain amino ...
Basel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has ...
The U.S. FDA’s recent approval of Nucala for chronic obstructive pulmonary disease (COPD) and a positive recommendation from the Committee for Medicinal Products for Human Use (CHMP) for Blenrep ...
(NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Ltd., today announced that the Committee for Medicinal Products for Human Use (CHMP) of ...
11d
Zacks.com on MSNAZN Gets CHMP Nod for Imfinzi in Muscle-Invasive Bladder CancerAstraZeneca wins CHMP nod for Imfinzi combo in muscle-invasive bladder cancer, based on data from the phase III NIAGARA study ...
GSK plc has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results